Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade
Junjie Li, Yuandong Luo, Quanlan Fu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Targeted therapy for multiple myeloma: an overview on CD138-based strategies
Federico Riccardi, Carmela Tangredi, Michele Dal Bo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real‐World Data
Minna Harmanen, Mika Hujo, Reijo Sund, et al.
Hematological Oncology (2025) Vol. 43, Iss. 1
Closed Access
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study
Javier García Corbacho, Alberto Indacochea, Iván Victoria, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended‐Gate Field‐Effect‐Transistor Biosensors
Trang‐Anh Nguyen‐Le, Christin Neuber, Isli Cela, et al.
Small Science (2025)
Open Access
Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer
P. Travis Courtney, Puja Venkat, Ya‐Chen Tina Shih, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250033-e250033
Open Access
The Influence of Indisulam on Human Immune Effector Cells: Is a Combination with Immunotherapy Feasible?
Lisa Arnet, Lisabeth Emilius, Alf Hamann, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 368-368
Open Access
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Overcoming Financial and Access Barriers in Global Cancer Care With Low-Dose Immunotherapy: A Systematic Review
Celine Hoyek, Binbin Zheng-Lin, Jennah J. Bauernfeind, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Cost of Neoadjuvant Immunotherapy vs Up-Front Surgery in Cutaneous Squamous Cell Carcinoma
Shannon S. Wu, A. Dimitrios Colevas, Luis F. Martinez-Ramirez, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly
Jacob J. Adashek, Jillian A. Moran, Dung T. Le, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
Biological mechanisms of resistance to immune checkpoint inhibitors and overcoming this resistance: Challenges in medical oncology
Yuliia Moskalenko
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 1, pp. 83-91
Open Access | Times Cited: 3
Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis
Kavita A. Iyer, Julian Ivanov, Rumiana Tenchov, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8519-8544
Open Access | Times Cited: 2
Integrative Approaches in Non-Small Cell Lung Cancer Management: The Role of Radiotherapy
Maxime Visa, Mohamed E. Abazeed, Diego M. Avella Patino
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4296-4296
Open Access | Times Cited: 2
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Justin Harper, Michael R. Betts, Mathias Lichterfeld, et al.
Pathogens and Immunity (2024) Vol. 8, Iss. 2, pp. 115-157
Open Access | Times Cited: 1
mRNA vaccines in gastric cancer: How close are we?
José Darío Portillo‐Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 88-96
Closed Access | Times Cited: 1
An ion channel-based prognostic model identified TRPV2 and GJB3 as immunotherapy determinants in pancreatic cancer
Jiakai Mao, Yu Tian, Nan Luo
Heliyon (2024) Vol. 10, Iss. 7, pp. e27301-e27301
Open Access | Times Cited: 1
A commentary on ‘Worldwide research trends on tumor burden and immunotherapy: A bibliometric analysis’
Lele Miao, Juan Zhang, Chaoyan Shen, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 1
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Yiyuan Feng, Caiying He, Chang Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6444-6444
Open Access | Times Cited: 1
Epigenetic regulation of cGAS and STING expression in cancer
Chuanxiang Zhao, Shuwei Guo, Shiyao Ge
International Immunopharmacology (2024) Vol. 138, pp. 112556-112556
Closed Access | Times Cited: 1
Towards Precision CAR T-cell Immunotherapy: extended gate FET biosensor for personalized drug monitoring
Trang‐Anh Nguyen‐Le, Christin Neuber, Isli Cela, et al.
(2024)
Open Access | Times Cited: 1
The rapid rise of the UK’s cancer vaccine trials
Chris Baraniuk
BMJ (2024), pp. q2294-q2294
Closed Access | Times Cited: 1
Financial toxicity of total cancer care immunotherapy patients and caregivers: impacts of COVID-19 pandemic and inflation
Irene Liang, Djin Tay, Anne C. Kirchhoff, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 12
Closed Access | Times Cited: 1
Immunotherapy in Colorectal Cancer: Statuses and Strategies
Yuan Li, Zewei Cheng, Shengli Li, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41354-e41354
Open Access | Times Cited: 1
mRNA vaccines in gastric cancer: How close are we?
José Darío Portillo‐Miño, David Bettin-Gonzalez, Franco Andrés Montenegro Coral
Vacunas (2023) Vol. 25, Iss. 1, pp. 88-96
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top